Persistence and Antiviral Resistance of Varicella Zoster Virus in Hematological Patients

Resistance testing of clinical varicella-zoster virus strains

(2011) Andreas Sauerbrei et al.   ANTIVIRAL RESEARCH

Compartmentalization of Acyclovir-Resistant Varicella Zoster Virus: Implications for Sampling in Molecular Diagnostics

(2011) A. A. T. P. Brink et al.   CLINICAL INFECTIOUS DISEASES

In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs

(2011) G. Andrei et al.   JOURNAL OF VIROLOGY

Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet

(2011) Karoline Bleymehl et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT

(2010) A Klein et al.   BONE MARROW TRANSPLANTATION

Herpes Viruses in Transplant Recipients: HSV, VZV, Human Herpes Viruses, and EBV

(2010) Kevin Shiley et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

(2010) Anne A. Gershon et al.   JOURNAL OF CLINICAL VIROLOGY

Persistence of varicella-zoster virus viraemia in patients with herpes zoster

(2010) M.L. Quinlivan et al.   JOURNAL OF CLINICAL VIROLOGY

One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group

(2010) K. Oshima et al.   Transplant Infectious Disease

Incidence and Risk of Postherpetic Neuralgia after Varicella Zoster Virus Infection in Hematopoietic Cell Transplantation Recipients: Hokkaido Hematology Study Group

(2009) Masahiro Onozawa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Visceral Varicella Zoster Virus (VZV) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Pediatric Patients With Chronic Graft-Versus-Host Disease (cGVHD)

(2009) David C. Peritz et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Identification of Varicella-Zoster Virus-Specific CD8 T Cells in Patients after T-Cell-Depleted Allogeneic Stem Cell Transplantation

(2009) P. L. J. van der Heiden et al.   JOURNAL OF VIROLOGY

Foscarnet Salvage Therapy for Acyclovir-Resistant Varicella Zoster

(2009) Todd Hatchette et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Varicella-Zoster Virus Disease Is More Frequent after Cord Blood Than after Bone Marrow Transplantation

(2008) Kristel Vandenbosch et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation

(2008) Eva Distler et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders

(2007) D.H. Kim et al.   Transplant Infectious Disease